| Combination therapy with anti-pvrig antibodies formulations, anti-tigit … |
2022-10-17 |
2023-4-20 |
|
| Anti-tigit and anti-pvrig in monotherapy and combination treatments |
2022-7-01 |
2023-1-05 |
|
| Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 … |
2022-5-01 |
2022-7-01 |
|
| Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof |
2022-4-28 |
2022-8-09 |
|
| Anti-pvrig antibodies and methods of use |
2022-4-14 |
2022-7-20 |
|
| Combination therapy with anti-pvrig antibodies formulations and anti-pd-1 … |
2022-1-28 |
2023-3-09 |
|
| Anti-pvrig antibodies formulations and uses thereof |
2022-1-28 |
2022-8-04 |
|
| Anti-pvrig antibodies formulations and uses thereof |
2022-1-26 |
2022-3-01 |
|
| Triple combination antibody therapies |
2021-12-07 |
2023-3-09 |
|
| Anti-tigit antibodies, anti-pvrig antibodies and combinations of these ( … |
2021-10-28 |
2022-7-29 |
|
| Pvrl2 and/or pvrig as biomarkers for treatment |
2021-10-26 |
2022-6-09 |
|
| Combinations of anti-ildr2 antibodies and pd-1 antagonists |
2021-10-07 |
2021-12-01 |
|
| Combination therapy with anti-pvrig antibodies formulations, anti-tigit … |
2021-9-30 |
2022-4-07 |
|
| Polypeptides and polynucleotides, and uses thereof for treatment of immune … |
2021-5-18 |
2022-2-17 |
|
| Bispecific anti-pvrig / anti-tigit antibodies and methods of use |
2020-12-30 |
2021-1-18 |
|
| Anti-pvrig and anti-tigit antibodies for enhanced nk-cell based tumor killing |
2020-12-07 |
2021-6-10 |
|
| Polypeptides and uses thereof for treatment of autoimmune disorders and … |
2020-11-18 |
2022-10-06 |
|
| Ildr2 antagonists and combinations thereof |
2020-5-18 |
2020-7-30 |
|
| Pvrig polypeptides and methods of treatment |
2020-1-28 |
2020-12-10 |
|
| C10rf32 antibodies, and uses thereof for treatment of cancer |
2019-5-14 |
2020-1-02 |
|
| Polypeptides and polynucleotides, and uses thereof as a drug target for … |
2019-4-05 |
2019-5-31 |
|
| C1orf32 antibodies, and uses thereof for treatment of cancer |
2019-1-11 |
2019-6-20 |
|
| Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, … |
2018-10-15 |
2019-8-01 |
|
| Polypeptides and uses thereof as a drug for treatment of autoimmune disorders |
2018-7-17 |
2019-10-10 |
|
| Anti-vsig10 antibodies and methods of use |
2018-6-08 |
2020-8-27 |
|
| Polypeptides and polynucleotides, and uses thereof as drug target for producing … |
2018-1-05 |
2018-7-12 |
|
| Hide1 compositions and methods |
2017-12-11 |
2022-6-01 |
|
| Anti-tigit antibodies, anti-pvrig antibodies and combinations thereof |
2017-8-17 |
2022-8-26 |
|
| Polypeptides and polynucleotides, and uses thereof as a drug target for … |
2016-11-29 |
2017-4-20 |
|
| Anti-vsig1 antibodies and drug conjugates |
2016-10-14 |
2017-4-20 |
|
| HIDE1 Compositions and Methods |
2016-7-13 |
2022-5-26 |
2022-5-26 |
| Methods for predicting hepatotoxicity |
2016-6-02 |
2016-12-08 |
|
| Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, … |
2016-4-30 |
2017-8-17 |
|
| Soluble vegfr-1 variants and assays and methods of use thereof for diagnosis |
2016-4-11 |
2016-7-28 |
|
| Anti-vstm5 antibodies and the use thereof in therapy and diagnosis |
2016-3-13 |
2016-4-21 |
|
| Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, … |
2016-3-10 |
2016-12-01 |
|
| Biomarkers for the prediction of renal injury |
2016-1-07 |
2016-6-23 |
|
| FAM26F polypeptides and polynucleotides, and uses thereof as a drug target for … |
2015-12-23 |
2016-1-21 |
|
| Polypeptides and uses thereof as a drug for treatment of autoimmune disorders |
2015-8-26 |
2016-3-03 |
|
| Compositions and methods for treatment of drug resistant multiple myeloma |
2015-2-27 |
2015-10-22 |
|
| Bioactive peptides and methods of using same |
2015-2-23 |
2015-10-29 |
|
| Anti-VSTM5 antibodies and the use thereof in therapy and diagnosis |
2014-9-11 |
2016-3-17 |
|
| Method of treating an ischemia-reperfusion injury-related disorder by … |
2014-9-07 |
2015-1-01 |
|
| C10rf32 antibodies , and uses thereof for treatment of cancer |
2014-4-29 |
2014-6-30 |
|
| Lsr antibodies, and uses thereof for treatment of cancer |
2014-4-29 |
2014-6-30 |
|
| FAM26F polypeptides and polynucleotides, and uses thereof as a drug target for … |
2014-2-26 |
2014-3-20 |
|
| Lsr antibodies, and uses thereof for treatment of cancer |
2013-6-19 |
2017-10-27 |
|
| Angiopoietin derived peptides |
2013-6-18 |
2014-1-02 |
|
| Polypeptides and polynucleotides, and uses thereof as a drug target for … |
2013-5-29 |
2013-11-28 |
|
| Polypeptides and polynucleotides related to fxyd3, and uses thereof as a drug … |
2013-4-12 |
2013-5-16 |
|
| Polypeptides and polynucleotides, and uses thereof for treatment of immune … |
2012-4-16 |
2016-3-01 |
|
| Genetic markers for prognosis of rheumatoid arthritis treatment efficacy |
2012-2-12 |
2015-6-17 |
|
| New cell-penetrating peptides and uses thereof |
2011-12-26 |
2012-7-05 |
|
| Biomarkers for the prediction of renal injury |
2011-8-23 |
2011-11-30 |
|
| Variants of vascular endothelial growth factor (vegf) receptor and use thereof |
2011-2-28 |
2011-9-01 |
|
| Heparanase splice variant |
2010-11-30 |
2016-8-30 |
2016-8-30 |
| Novel gp96 derived peptides |
2010-9-07 |
2010-12-30 |
|
| Polypeptides and polynucleotides, and uses thereof as a drug target for … |
2010-7-21 |
2010-12-30 |
|
| Biomarkers for the prediction of renal injury |
2010-6-24 |
2010-12-30 |
|
| Methods and systems for annotating biomolecular sequences |
2010-4-23 |
2011-7-28 |
|
| Novel diagnostic markers, especially for in vivo imaging, and assays and … |
2010-4-12 |
2010-7-29 |
|
| Hepatocyte growth factor receptor splice variants and methods of using same |
2010-2-19 |
2010-7-22 |
|
| He4 variant nucleotide and amino acid sequences, and methods of use thereof |
2009-11-30 |
2010-6-03 |
|
| Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use … |
2009-11-23 |
2010-9-30 |
|
| Allelic polymorphism associated with diabetes |
2009-10-29 |
2010-6-16 |
|
| Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use … |
2009-9-10 |
2010-3-18 |
|
| Novel gp96-derived peptide |
2009-3-12 |
2011-4-28 |
|
| Novel clusterin derived peptide |
2009-1-22 |
2010-12-23 |
|
| Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of use … |
2009-1-15 |
2010-5-20 |
|
| Novel nucleotide and amino acid sequences, and assays and methods of use … |
2009-1-08 |
2009-11-19 |
|
| Mcp-1 splice variants and methods of using same |
2008-12-18 |
2011-8-01 |
|
| POLYPEPTIDES AND POLYNUCLEOTIDES AND USES THEREOF AS a drug FOR THE PRODUCTION … |
2008-9-03 |
2015-5-26 |
2015-5-26 |
| Use of nmda receptor antagonists for treatment of urologic tumors |
2008-7-31 |
2009-12-30 |
|
| Compositions comprising tetracyclic antidepressants for treatment of cancer and … |
2008-7-30 |
2009-12-30 |
|
| Allelic polymorphism associated with diabetes |
2008-4-30 |
2010-2-24 |
|
| Hepatocyte growth factor receptor splice variants and methods of using same |
2008-3-24 |
2008-11-03 |
|
| Novel nucleotide and amino acid sequences, and methods of use thereof for … |
2007-12-30 |
2010-10-14 |
|
| Novel nucleotide and amino acid sequences, and assays and methods of use … |
2007-12-06 |
2008-3-20 |
|
| Novel brain natriuretic peptide variants and methods of use thereof |
2007-10-29 |
2008-7-31 |
|
| Novel nucleotide and amino acid sequences, and assays methods of use thereof … |
2007-10-23 |
2009-8-27 |
|
| Novel nucleic acid sequences and methods of use thereof for diagnosis |
2007-7-31 |
2009-3-19 |
|
| Hepatocyte growth factor receptor splice variants and methods of using same |
2007-7-23 |
2010-3-16 |
2010-3-16 |
| Novel nucleotide and amino acid sequences, and assays and methods of use … |
2007-6-19 |
2008-1-17 |
|
| Novel nucleotide and amino acid sequences and methods of use thereof for … |
2007-3-21 |
2007-9-27 |
|